By the end of 2007, a total of 178 institutions conducting clinical trials had obtained Good Clinical Practice (GCP) certification, said a white paper published on Friday by the Information Office of the State Council.
China promotes GCP certification for drug clinical trials, states the white paper.
To ensure scientifically accurate reflection and reliability of results as well as test subjects' rights and interests during clinical trials, China promulgated the Good Clinical Practice (GCP) for pharmaceutical products in 1999, and began the work of GCP certification on March 1, 2004, says the paper.
By the end of 2007, a total of 178 institutions conducting clinical trials had obtained GCP certification, and GCP certification has greatly improved the quality of drug clinical trials in China, it says.
Meanwhile, an increasing number of international multi-centered clinical trials are being carried out in China, according to the paper.
Source: Xinhua
|
Comment
Tell A Friend
Print Format
Save Article